NHS National Framework Agreement for the Supply of products for the management of Hereditary Angioedema

  • NHS England

F14: Notice for changes or additional information

Notice identifier: 2022/S 000-019862

Procurement identifier (OCID): ocds-h6vhtk-0314ad

Published 21 July 2022, 11:44am



Section one: Contracting authority/entity

one.1) Name and addresses

NHS England

Quarry House

Leeds

LS2 7UE

Contact

Philip Grieve

Email

philip.grieve@nhs.net

Country

United Kingdom

NUTS code

UKE - Yorkshire and the Humber

Internet address(es)

Main address

https://www.england.nhs.uk//

Buyer's address

https://www.england.nhs.uk//


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NHS National Framework Agreement for the Supply of products for the management of Hereditary Angioedema

Reference number

CM/PHS/19/5583

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2022/S 000-019699


Section seven. Changes

seven.1.2) Text to be corrected in the original notice

Section number

I.1.5

Place of text to be modified

NUTS code

Instead of
Text

UKE

Read
Text

UK